India's Wockhardt jumps; US FDA accepts application for antibiotic Zaynich - TradingView3 hours ago • Google News
Investors in Wockhardt (NSE:WOCKPHARMA) have seen massive returns of 469% over the past three years - simplywall.st2025-10-14 • Google News
Wockhardt Pharma Shares: SEBI Analyst Says Dip Could Be A Buying Chance As Long As ₹1,400 Holds - Stocktwits2025-09-04 • Google News